Pharmacogenomics of microRNA: a miRSNP towards individualized therapy (Q46845992)

25 December 2017

editorial

0 references

title

Pharmacogenomics of microRNA: a miRSNP towards individualized therapy (English)

1 reference

25 December 2017

1 reference

1 reference

Joseph R Bertino

1

1 reference

25 December 2017

Debabrata Banerjee

series ordinal

2

1 reference

25 December 2017

Prasun J Mishra

series ordinal

3

1 reference

25 December 2017

publication date

1 December 2007

1 reference

25 December 2017

published in

Pharmacogenomics

1 reference

25 December 2017

volume

8

1 reference

25 December 2017

issue

12

1 reference

25 December 2017

page(s)

1625-1627

1 reference

25 December 2017

A miR-24 microRNA binding-site polymorphism in dihydrofolate reductase gene leads to methotrexate resistance

cites work

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.12.1625

Phylogenetic shadowing and computational identification of human microRNA genes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.12.1625

Systematic discovery of regulatory motifs in human promoters and 3' UTRs by comparison of several mammals

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.12.1625

Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.12.1625

Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.12.1625

Translation of pharmacogenomics and pharmacogenetics: a regulatory perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.12.1625

Pharmacogenetics, pharmacogenomics and personalized medicine: are we there yet?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.12.1625

Moving towards individualized medicine with pharmacogenomics

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.12.1625

Acute lymphoblastic leukaemia: a model for the pharmacogenomics of cancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.12.1625

MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.12.1625

Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.12.1625

Translational control by the 3'-UTR: the ends specify the means.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.12.1625

Polymorphism in the 3'-untranslated region of the thymidylate synthase gene and sensitivity of stomach cancer to fluoropyrimidine-based chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.12.1625

MicroRNAs repress translation of m7Gppp-capped target mRNAs in vitro by inhibiting initiation and promoting deadenylation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.12.1625

Involvement of microRNA in AU-rich element-mediated mRNA instability

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.12.1625

10.2217/14622416.8.12.1625

21 January 2018

Identifiers

DOI

1 reference

25 December 2017

1 reference

25 December 2017